Artificial Intelligence (AI) in Healthcare: Strategic Intelligence

Artificial intelligence (AI) in healthcare market analysis and strategic intelligence. Explore artificial intelligence trends, healthcare AI adoption, drug discovery, diagnostics, medical devices, and competitive benchmarking through 2029. AI is transforming healthcare through automation, analytics, and the development of smarter clinical tools. Across healthcare providers, pharmaceuticals, and medical devices, the combined AI market was valued at $11.9 billion in 2024 and is expected to reach $57.4 billion by 2029, representing a compound annual growth rate (CAGR) of about 37%.

Navigate the Future of AI in Healthcare with Strategic Intelligence

Artificial intelligence is rapidly transforming healthcare. What began as a set of experimental tools is now becoming a core enabler of clinical decision-making, operational efficiency, diagnostics, drug discovery, and personalized medicine.

GlobalData’s Artificial Intelligence (AI) in Healthcare: Strategic Intelligence report helps you understand where AI is creating value today and where future opportunities may emerge. The combined AI market across healthcare providers, pharmaceuticals, and medical devices was valued at $11.9 billion in 2024 and is projected to reach $57.4 billion by 2029, representing a CAGR of approximately 37%.

As AI adoption accelerates, healthcare leaders face important strategic questions. Which AI applications are delivering measurable returns? Which companies are leading innovation? How are regulations evolving? And where should organizations invest to remain competitive?

This report provides insight into these critical questions and helps support informed decision-making across the healthcare ecosystem.

Report Value Proposition – Why This AI in Healthcare Report Matters

Many organizations understand AI’s potential. However, identifying practical opportunities and avoiding costly mistakes remains challenging.

This report goes beyond technology trends to help you evaluate the business implications of AI adoption across healthcare.

You can use this research to:

• Identify the most commercially viable AI applications in healthcare
• Assess investment opportunities across providers, pharma, and medtech
• Benchmark AI strategies against global industry leaders
• Support digital transformation and innovation initiatives
• Evaluate competitive threats and emerging market entrants
• Understand how AI may reshape healthcare value chains through 2029
• Inform partnership, acquisition, and ecosystem development strategies
• Track regulatory and commercialization developments affecting AI adoption

As a result, you gain a clearer view of where AI is generating measurable value and where future growth opportunities may emerge.

How Healthcare Leaders Are Using This Intelligence

Healthcare decision-makers are leveraging this report to:

• Prioritize AI investments with confidence: Identify the AI applications delivering the strongest ROI across care delivery, diagnostics, and life sciences, and avoid overhyped or premature use cases.

• Shape AI adoption and scaling strategies: Move beyond pilots by understanding where AI is already being commercialized and how leading organizations are integrating it into core workflows.

• Guide product and platform development: Align AI-enabled products and services with real clinical and operational needs, regulatory readiness, and buyer expectations.

• Strengthen partnerships and ecosystem plays: Benchmark technology vendors, platform providers, and collaborators to build resilient AI ecosystems across healthcare value chains.

• Future-proof healthcare strategy: Anticipate regulatory, technological, and competitive shifts to ensure AI strategies remain compliant, scalable, and sustainable through 2029 and beyond.

Scope

Key AI in Healthcare Trends Covered in This Report

The report analyzes how artificial intelligence is transforming multiple areas of healthcare.

AI-Powered Healthcare Delivery

Healthcare providers are increasingly deploying AI solutions to improve operational efficiency, reduce administrative burden, and enhance patient care.

The report explores:

• Clinical decision support systems
• Workflow automation
• Patient engagement technologies
• Predictive analytics
• Healthcare operations optimization

AI in Drug Discovery and Pharmaceutical R&D

Artificial intelligence is becoming a critical tool across the pharmaceutical value chain.

The report examines how AI is helping organizations:

• Accelerate target identification
• Improve molecule design
• Optimize clinical trial recruitment
• Generate real-world evidence
• Enhance drug development productivity

AI in Medical Devices and Diagnostics

Regulatory momentum and technological advances are supporting increased adoption of AI-enabled diagnostics and imaging systems.

Key areas include:

• AI-powered medical imaging
• Radiology applications
• Pathology diagnostics
• Robotics and automation
• Intelligent medical devices

AI Infrastructure and Platforms

The report also evaluates the technology ecosystem supporting AI commercialization, including:

• • AI consulting services
  • AI software platforms
  • Healthcare-specific AI applications
  • Specialized AI hardware solutions
  • Strategic technology partnerships

Benchmark Against Global Leaders in AI Healthcare Innovation

Understanding how leading organizations are approaching AI can provide valuable competitive insight.

This report analyzes major healthcare and life sciences organizations, including:

• AstraZeneca
• Pfizer
• Roche
• Novartis
• Johnson & Johnson
• GE Healthcare
• Siemens Healthineers
• Medtronic
• Illumina

Through company analysis, sector scorecards, case studies, and value chain assessments, you can benchmark your organization’s position against established leaders and emerging innovators.

Who Should Buy This Report?

This report is designed for decision-makers responsible for innovation, growth, investment, and digital transformation.

Target buyers include:

• Chief Executive Officers (CEOs)
• Chief Digital Officers (CDOs)
• Chief Information Officers (CIOs)
• Chief Medical Officers (CMOs)
• Heads of AI and Data Science
• Healthcare Strategy Leaders
• Pharmaceutical R&D Executives
• Medical Device Innovation Teams
• Digital Health Leaders
• Business Development and Partnership Teams
• Corporate Strategy Teams
• Market Intelligence Professionals
• Healthcare Investors and Private Equity Firms
• Management Consultants
• Government and Healthcare Policymakers

Comprehensive Coverage Across the Healthcare AI Value Chain

The report includes detailed analysis of:

• Executive summary and strategic outlook
• Healthcare AI market landscape
• Key players shaping AI adoption
• AI value chain analysis
• The impact of AI across healthcare sectors
• Real-world case studies
• Company profiles and competitive positioning
• Sector scorecards
• Emerging opportunities and challenges
• Strategic implications through 2029

Furthermore, the report examines the technological, regulatory, and commercial factors influencing AI deployment at scale.

Reasons to Buy

• Understand where AI is delivering real value in healthcare: Gain a clear view of how AI is being applied across clinical, operational, and R&D functions and where adoption is scaling fastest.

• Benchmark leading players and technologies: Identify the companies shaping the AI in healthcare ecosystem and understand how incumbents and innovators are positioning for long-term growth.

• Anticipate the future of AI-driven healthcare: Access forward-looking insights into technology, regulatory, and investment trends to inform strategic planning, partnerships, and product development.

Trusted Intelligence from GlobalData

This report is built on GlobalData’s proprietary thematic intelligence framework and extensive healthcare market expertise.

You benefit from:

• Trusted research used by Fortune 500 companies worldwide
• Comprehensive thematic analysis and competitive benchmarking
• Coverage of leading healthcare, pharmaceutical, and medtech innovators
• Insights from analysts with decades of healthcare sector expertise
• Integrated market, technology, company, and strategic intelligence

This approach helps you connect emerging technologies to real-world business outcomes.

Take Action Before AI Adoption Widens the Competitive Gap

AI is moving beyond experimentation and into mainstream healthcare operations, diagnostics, and drug development.

Organizations that understand where adoption is accelerating may be better positioned to capture opportunities, build competitive advantages, and navigate industry disruption.

If you are evaluating healthcare AI investments, digital transformation initiatives, competitive threats, or innovation opportunities, this report provides the strategic intelligence needed to support timely and informed decisions.